National Library of Medicine; Notice of Closed Meetings, 49289 [07-4223]
Download as PDF
Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assisance, National Institutes of Health,
HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4215 Filed 8–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meetings
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; G08–R01–
R21.
Date: October 15, 2007.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20817 (Telephone Conference Call).
Contact Person: Zoe E. Huang, MD, Health
Scientific Administrator, Extramural
Programs, National Library of Medicine,
Rockledge 1 Building, 6705 Rockledge Drive,
Suite 301, Bethesda, MD 20892–7968, 301–
594–4937, huangz@mail.nih.gov.
Name of Committee: Biomedical Library
and Informatics Review Committee.
Date: November 6–7, 2007.
Time: November 6, 2007, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 9000
Rockville Pike, Bethesda, MD 20894.
Time: November 7, 2007, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Aug<31>2005
19:52 Aug 27, 2007
Jkt 211001
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 9000
Rockville Pike, Bethesda, MD 20894.
Contact Person: Arthur A. Petrosian, PhD,
Scientific Review Administrator, Division of
Extramural Programs, National Library of
Medicine, 6705 Rockledge Drive, Suite 301,
Bethesda, MD 20892–7968, 301–496–4253,
petrosia@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs. hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4223 Filed 8–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: FDA Cleared Pediatric Cancer
Diagnostics and Prognostics
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(I), that the National
Institutes of Health (NIH), Department
of Health and Human Services, is
contemplating the grant of an exclusive
license to practice the invention
embodied in Patent Applications U.S.
10/133,937, filed 04/25/2002, entitled
‘‘Methods for Analyzing High
Dimensional Data for Classifying,
Diagnosing, Prognosticating and/or
Predicting Diseases and Other Biological
States’’; and U.S. 10/159,563, filed 05/
31/2002, entitled ‘‘Selections of Genes
And Methods of Using The Same For
Diagnosis And For Targeting The
Therapy of Select Cancers’’; to Althea
Technologies, Inc. having a place of
business in San Diego, California. The
patent rights in this invention have been
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
49289
assigned to the United States of America
(PHS ref E–324–2001/0,1).
DATE: Only written comments and/or
application for a license that are
received by the NIH Office of
Technology Transfer on or before
October 29, 2007 will be considered.
ADDRESS: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Cristina Thalhammer-Reyero, Ph.D.,
M.B.A., Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; e-mail:
ThalhamC@mail.nih.gov; Telephone:
301–435–4507; Facsimile: 301–402–
0220.
SUPPLEMENTARY INFORMATION: The
prospective exclusive license will be
royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 60 days from the date of this
published Notice, NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7.
The invention relates to a method of
using supervised pattern recognition
methods for classifying, diagnosing,
predicting, or prognosticating various
diseases. The method includes
obtaining high dimensional
experimental data, such as gene
expression profiling data, filtering the
data, reducing the dimensionality of the
data through use of one or more
methods, training artificial neural
networks (ANN, a supervised pattern
recognition method), ranking individual
data points from the data, choosing
multiple data points from the data based
on the relative ranking, and using the
multiple data points to determine if an
unknown set of experimental data
indicates a diseased condition, a
predilection for a diseased condition, or
a prognosis about a diseased condition.
Further, the invention relates to sets of
genes expressed in cancer cells that
function to characterize each cancer
type, and methods of using the sets of
genes for diagnosis and for targeting the
therapy of selected cancers. In
particular, the methods apply to classify
cancers which often present diagnostic
dilemmas in clinical practice, such as
the pediatric small round blue cell
tumors (SRBCTs), including
neuroblastoma (NB),
rhabdomyosarcoma (RMS), Burkitt’s
lymphoma (BL), and the Ewing family
of tumors (EWS). Specifically, the
invention is an application of ANNs for
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 72, Number 166 (Tuesday, August 28, 2007)]
[Notices]
[Page 49289]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4223]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Library of Medicine Special Emphasis
Panel; G08-R01-R21.
Date: October 15, 2007.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Library of Medicine, 6705 Rockledge Drive, Suite
301, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Zoe E. Huang, MD, Health Scientific
Administrator, Extramural Programs, National Library of Medicine,
Rockledge 1 Building, 6705 Rockledge Drive, Suite 301, Bethesda, MD
20892-7968, 301-594-4937, huangz@mail.nih.gov.
Name of Committee: Biomedical Library and Informatics Review
Committee.
Date: November 6-7, 2007.
Time: November 6, 2007, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 9000 Rockville Pike, Bethesda, MD 20894.
Time: November 7, 2007, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 9000 Rockville Pike, Bethesda, MD 20894.
Contact Person: Arthur A. Petrosian, PhD, Scientific Review
Administrator, Division of Extramural Programs, National Library of
Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892-7968,
301-496-4253, petrosia@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs. hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.879,
Medical Library Assistance, National Institutes of Health, HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4223 Filed 8-27-07; 8:45 am]
BILLING CODE 4140-01-M